Decentralised pre-surgery testing boosts operating room activity in Spain:
This article was originally published in Clinica
A Spanish hospital is claiming a breakthrough in making more efficient its management of surgical patients, by performing pre-anaesthetic testing at local health centres. Until now, the Reina Sofia University Hospital, in Cordoba, Andalucia, has performed this testing for all the patients the hospital group receives from across the province, forcing them to travel often great distances, while imposing an extra organisational burden on the hospital. These factors were found to significantly affect OR throughput, adding to the hospital's surgical waiting list. This currently numbers 5,000 patients, of whom 60% have waited less than two months, and 14% between four and six months. The four hospitals in the Reina Sofia group performed 33,400 operations in 2005, up 7.7% on the previous year.
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.